Literature DB >> 28233195

Ultrastructural and biochemical basis for hepatitis C virus morphogenesis.

Viviana Falcón1, Nelson Acosta-Rivero2,3, Sirenia González4, Santiago Dueñas-Carrera5, Gillian Martinez-Donato5, Ivon Menéndez5, Rocio Garateix5, José A Silva5, Emilio Acosta6, Juan Kourı4.   

Abstract

Chronic infection with HCV is a leading cause of cirrhosis, hepatocellular carcinoma and liver failure. One of the least understood steps in the HCV life cycle is the morphogenesis of new viral particles. HCV infection alters the lipid metabolism and generates a variety of microenvironments in the cell cytoplasm that protect viral proteins and RNA promoting viral replication and assembly. Lipid droplets (LDs) have been proposed to link viral RNA synthesis and virion assembly by physically associating these viral processes. HCV assembly, envelopment, and maturation have been shown to take place at specialized detergent-resistant membranes in the ER, rich in cholesterol and sphingolipids, supporting the synthesis of luminal LDs-containing ApoE. HCV assembly involves a regulated allocation of viral and host factors to viral assembly sites. Then, virus budding takes place through encapsidation of the HCV genome and viral envelopment in the ER. Interaction of ApoE with envelope proteins supports the viral particle acquisition of lipids and maturation. HCV secretion has been suggested to entail the ion channel activity of viral p7, several components of the classical trafficking and autophagy pathways, ESCRT, and exosome-mediated export of viral RNA. Here, we review the most recent advances in virus morphogenesis and the interplay between viral and host factors required for the formation of HCV virions.

Entities:  

Keywords:  Hepatitis C virus; Viral life cycle; Virus morphogenesis; Virus replication; Virus–host interactions

Mesh:

Substances:

Year:  2017        PMID: 28233195     DOI: 10.1007/s11262-017-1426-2

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  145 in total

1.  Sphingomyelin activates hepatitis C virus RNA polymerase in a genotype-specific manner.

Authors:  Leiyun Weng; Yuichi Hirata; Masaaki Arai; Michinori Kohara; Takaji Wakita; Koichi Watashi; Kunitada Shimotohno; Ying He; Jin Zhong; Tetsuya Toyoda
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

2.  Mature VLDL triggers the biogenesis of a distinct vesicle from the trans-Golgi network for its export to the plasma membrane.

Authors:  Tanvir Hossain; Aladdin Riad; Shaila Siddiqi; Sampath Parthasarathy; Shadab A Siddiqi
Journal:  Biochem J       Date:  2014-04-01       Impact factor: 3.857

3.  Expression of hepatitis C virus (HCV) structural proteins in trans facilitates encapsidation and transmission of HCV subgenomic RNA.

Authors:  Richard Adair; Arvind H Patel; Lynsey Corless; Stephen Griffin; David J Rowlands; Christopher J McCormick
Journal:  J Gen Virol       Date:  2009-02-17       Impact factor: 3.891

4.  Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus.

Authors:  Christopher T Jones; Catherine L Murray; Dawnnica K Eastman; Jodie Tassello; Charles M Rice
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

5.  Hepatitis C virus particle detected by immunoelectron microscopic study.

Authors:  M Kaito; S Watanabe; K Tsukiyama-Kohara; K Yamaguchi; Y Kobayashi; M Konishi; M Yokoi; S Ishida; S Suzuki; M Kohara
Journal:  J Gen Virol       Date:  1994-07       Impact factor: 3.891

Review 6.  The origin of hepatitis C virus.

Authors:  Peter Simmonds
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

7.  Function follows form: the structure of the N-terminal domain of HCV NS5A.

Authors:  Darius Moradpour; Volker Brass; Francois Penin
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

8.  Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1.

Authors:  Eva Herker; Charles Harris; Céline Hernandez; Arnaud Carpentier; Katrin Kaehlcke; Arielle R Rosenberg; Robert V Farese; Melanie Ott
Journal:  Nat Med       Date:  2010-10-10       Impact factor: 53.440

9.  Coordination of Hepatitis C Virus Assembly by Distinct Regulatory Regions in Nonstructural Protein 5A.

Authors:  Margarita Zayas; Gang Long; Vanesa Madan; Ralf Bartenschlager
Journal:  PLoS Pathog       Date:  2016-01-04       Impact factor: 6.823

10.  Identification of HNRNPK as regulator of hepatitis C virus particle production.

Authors:  Marion Poenisch; Philippe Metz; Hagen Blankenburg; Alessia Ruggieri; Ji-Young Lee; Daniel Rupp; Ilka Rebhan; Kathrin Diederich; Lars Kaderali; Francisco S Domingues; Mario Albrecht; Volker Lohmann; Holger Erfle; Ralf Bartenschlager
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

View more
  10 in total

1.  The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types.

Authors:  Solène Denolly; Chloé Mialon; Thomas Bourlet; Fouzia Amirache; François Penin; Brett Lindenbach; Bertrand Boson; François-Loïc Cosset
Journal:  PLoS Pathog       Date:  2017-12-18       Impact factor: 6.823

Review 2.  The 5BSL3.2 Functional RNA Domain Connects Distant Regions in the Hepatitis C Virus Genome.

Authors:  Cristina Romero-López; Alfredo Berzal-Herranz
Journal:  Front Microbiol       Date:  2017-10-31       Impact factor: 5.640

Review 3.  Global elimination of hepatitis C virus infection: Progresses and the remaining challenges.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Hepatol       Date:  2017-11-28

Review 4.  Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets.

Authors:  Nathalie Alazard-Dany; Solène Denolly; Bertrand Boson; François-Loïc Cosset
Journal:  Viruses       Date:  2019-01-06       Impact factor: 5.048

Review 5.  In vitro methods for testing antiviral drugs.

Authors:  Michaela Rumlová; Tomáš Ruml
Journal:  Biotechnol Adv       Date:  2017-12-29       Impact factor: 14.227

Review 6.  Recent Progress on Exosomes in RNA Virus Infection.

Authors:  Liying Zhang; Yichen Ju; Si Chen; Linzhu Ren
Journal:  Viruses       Date:  2021-02-08       Impact factor: 5.048

Review 7.  Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases.

Authors:  Ying Shi; Lingyao Du; Duoduo Lv; Yan Li; Zilong Zhang; Xiaolun Huang; Hong Tang
Journal:  J Gastroenterol       Date:  2021-03-04       Impact factor: 7.527

Review 8.  Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease.

Authors:  Siobhan Gargan; Nigel J Stevenson
Journal:  Viruses       Date:  2021-10-27       Impact factor: 5.048

9.  High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor.

Authors:  Anna Offersgaard; Carlos Rene Duarte Hernandez; Anne Finne Pihl; Nandini Prabhakar Venkatesan; Henrik Krarup; Xiangliang Lin; Udo Reichl; Jens Bukh; Yvonne Genzel; Judith Margarete Gottwein
Journal:  Vaccines (Basel)       Date:  2022-02-07

Review 10.  Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis.

Authors:  Daniela Bender; Eberhard Hildt
Journal:  Int J Mol Sci       Date:  2019-09-19       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.